申请人:——
                            
                            
                                公开号:US20030060462A1
                            
                            
                                公开(公告)日:2003-03-27
                            
                            The present invention provides compounds of formula I:
1
wherein R
1
, R
2
, R
3
, R
4
, Y, b, and c have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods for treating diseases wherein modulation of 5-HT activity is desired, as well as processes and intermediates useful for preparing compounds of formula I.
                            本发明提供了式 I 的化合物:
1
其中 R
1
, R
2
, R
3
, R
4
Y、b 和 c 具有说明书中定义的任一值,以及包含这些化合物的药物组合物。本发明还提供了用于治疗需要调节 5-HT 活性的疾病的治疗方法,以及用于制备式 I 化合物的工艺和中间体。